Torsdag 19 Mars | 14:20:29 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-03-05 08:00 Bokslutskommuniké 2026
2026-11-28 17:35 Kvartalsrapport 2026-Q3
2026-08-28 17:35 Kvartalsrapport 2026-Q2
2026-05-29 17:35 Kvartalsrapport 2026-Q1
2026-05-21 N/A Årsstämma
2026-03-27 08:00 Bokslutskommuniké 2025
2025-12-18 - Extra Bolagsstämma 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-29 - Kvartalsrapport 2025-Q1
2025-05-23 - X-dag ordinarie utdelning OPTI 0.00 SEK
2025-05-22 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-11-06 - Extra Bolagsstämma 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-31 - Kvartalsrapport 2024-Q1
2024-05-23 - Årsstämma
2024-05-17 - X-dag ordinarie utdelning OPTI 0.00 SEK
2024-03-28 - Bokslutskommuniké 2023
2024-02-27 - Bokslutskommuniké 2023
2023-11-28 - Kvartalsrapport 2023-Q3
2023-10-05 - Extra Bolagsstämma 2023
2023-08-29 - Kvartalsrapport 2023-Q2
2023-05-05 - Kvartalsrapport 2023-Q1
2023-03-09 - X-dag ordinarie utdelning OPTI 0.00 SEK
2023-03-08 - Årsstämma
2023-02-14 - Bokslutskommuniké 2022
2022-11-23 - Extra Bolagsstämma 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning OPTI 0.00 SEK
2022-05-25 - Årsstämma
2022-05-06 - Kvartalsrapport 2022-Q1
2022-02-09 - Bokslutskommuniké 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-06-28 - Årsstämma
2021-05-28 - Kvartalsrapport 2021-Q1
2021-05-14 - X-dag ordinarie utdelning OPTI 0.00 SEK
2021-03-05 - Extra Bolagsstämma 2021
2021-02-16 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-05 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-28 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-08-22 - Extra Bolagsstämma 2019
2019-05-23 - Kvartalsrapport 2019-Q1
2019-04-12 - X-dag ordinarie utdelning OPTI 0.00 SEK
2019-04-11 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-29 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-25 - X-dag ordinarie utdelning OPTI 0.00 SEK
2018-04-24 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-29 - Kvartalsrapport 2017-Q3
2017-08-29 - Kvartalsrapport 2017-Q2
2017-05-30 - Kvartalsrapport 2017-Q1
2017-03-15 - X-dag ordinarie utdelning OPTI 0.00 SEK
2017-03-14 - Årsstämma
2017-02-17 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-26 - Kvartalsrapport 2016-Q2
2016-05-26 - Kvartalsrapport 2016-Q1
2016-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2016-04-26 - Årsstämma
2016-02-25 - Bokslutskommuniké 2015
2015-11-26 - Kvartalsrapport 2015-Q3
2015-08-27 - Kvartalsrapport 2015-Q2
2015-05-28 - Kvartalsrapport 2015-Q1
2015-04-29 - X-dag ordinarie utdelning OPTI 0.00 SEK
2015-04-28 - Årsstämma
2015-02-26 - Bokslutskommuniké 2014
2014-11-26 - Kvartalsrapport 2014-Q3
2014-11-17 - Extra Bolagsstämma 2014
2014-08-29 - Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriForskning & Utveckling
OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå. Huvudkontoret ligger i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-16 08:30:00

As presented on March 8, OptiCept Technologies AB (publ) (“OptiCept”) has entered into a global commercialization agreement with FPS Food Process Solutions (“FPS”), one of the world’s leading suppliers of food processing equipment. At the same time, a comprehensive efficiency program and the conversion of loans into shares were also presented.

OptiCept will focus on its core competence in innovation and technological development. The approach means that OptiCept will drive commercialization through partners who have the capabilities to commercialize the technology developed by OptiCept. Going forward, the focus will be on identifying and entering into agreements with such partners.

OptiCept retains the right to commercialize entirely new verticals such as, for example, biogas (more efficient digestion), flowers and the forestry industry (pre-treatment). The agreement also means that OptiCept retains the opportunity to develop and commercialize verticals within large markets such as spirits, coffee and tea.

The vertical closest to commercialization is forest cuttings, where the company sees strong opportunities for a commercial breakthrough in the near future.

A Stronger OptiCept

After the implementation of these measures, OptiCept is positioned as a more scalable, technology-driven and capital-efficient company.

A More Scalable Company

OptiCept is now building a business model where growth requires a significantly smaller increase in its own resources compared with the previous approach. By allowing an established industrial partner to take primary responsibility for global commercialization, the company can benefit from the partner’s distribution network, customer relationships and production capacity. This creates conditions for faster international expansion with limited internal investments in sales organization and infrastructure.

A More Technology-Driven Company

In the new structure, OptiCept can focus to a greater extent on its core competence: innovation and technological development. The company concentrates its resources on further developing existing platforms, developing new applications and refining its IP portfolio within prioritized verticals. In this way, the technological level of the offering increases while competitive advantages are strengthened.

A More Capital-Efficient Company

By placing a larger part of the commercialization work with a partner, OptiCept reduces its need for heavy investments in production, inventory and global sales capacity. In the short term this frees up capital and in the long term it reduces capital requirements. The balance sheet is strengthened and indebtedness is reduced. A more cost- and capital-efficient structure creates, using internal resources, room for investments in research, development and selective growth initiatives with high returns.

A Company Focused on Long-Term Value Creation

With a working model where global commercialization is driven by established industrial partners, where OptiCept focuses on advanced technological development and where the balance sheet is gradually strengthened, good conditions are created for long-term profitable growth. The combination of a scalable revenue model, high technological competence and an improved financial position provides a stable foundation for delivering value to customers, shareholders and other stakeholders over time.

“We are very pleased that we have found a model where OptiCept can continue to develop its innovations and, together with partners such as FPS, quickly reach the market without large cost-intensive investments,” says Ulf Hagman, Chairman of the Board.

For further information, please contact

OptiCept Technologies AB (publ)
Ulf Hagman, Chairman of the Board
+46 73 363 63 80
ulf.hagman@opticept.se